Lexicon Pharma To Present Clinical Data On Adipose Tissue Distribution In Non-Diabetic Patients Treated With Sotagliflozin At CVCT 2025

Benzinga · 2d ago

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) announced clinical data on adipose tissue distribution in non-diabetic patients treated with sotagliflozin will be presented at the 22nd Global Cardio Vascular Clinical Trialists Forum (CVCT 2025). The conference is being held December 8-10, 2025, at the Mayflower Hotel in Washington, D.C.

This data is from SOTA-P-CARDIA, a prospective, randomized, double-blind, placebo-controlled trial that exclusively enrolled patients with heart failure with preserved ejection fraction (HFpEF) and was conducted by Mount Sinai Medical Center in New York City.